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ABSTRACT 
RIFIN proteins are variable surface antigens, which have a central role in the 
survival and virulence of the malaria parasite Plasmodium falciparum. Antigenic 
variation is a mean for these parasites to avoid clearance by the hostʼs immune 
system. However, this is often a secondary function to the main role of these 
proteins. In the case of RIFIN, P. falciparumʼs largest multicopy protein family, 
the main functions remain unknown. In order to elucidate a proteinʼs function, it 
is crucial to understand its basic properties, including the structure of the 
protein family, their localization and the proteinʼs topology.  
Through different methods, we have strived to simplify the RIFIN protein family 
into manageable entities. We have started with a simple classification of RIFIN 
proteins into meaningful sub-groups. We have predicted that these sub-groups 
are functionally distinct, although they probably share a related function. 
We then designed RSPred, an automatic method, based on hidden Markov 
models and a sorting program, to detect and classify RIFIN and STEVOR 
sequences according to their sub-group. 
Finally, using an in vitro method to determine protein topology, we have 
analyzed both A-RIFIN and B-RIFIN proteins for their number of 
transmembrane segments and their topologies. We show that both protein 
groups have a signal sequence targeting them to lipid bilayers and only one 
transmembrane domain. They both share a common topology where the bulk 
of the protein is exposed to the extracellular environment.  
With the current knowledge of RIFIN protein localizations, as well as the loss of 
expression of A-RIFIN but not B-RIFIN proteins in a splenectomized patient, it 
seems increasingly clear that B-RIFIN proteins are good targets for future 
studies, to decipher the functions of these variable proteins. 
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1 INTRODUCTION 
My thesis is mostly about a family of antigenic variant proteins called RIFIN, 
which are uniquely found in the parasite that causes the most dangerous form 
of malaria, Plasmodium falciparum. But before I go into the details of my work 
on this protein family, I will briefly introduce malaria in general, the 
Plasmodium parasites, as well as antigenic variation and specific protein 
families. 
 
1.1 MALARIA 
Among the top infectious diseases in the world malaria comes in third place, 
after tuberculosis and HIV, in terms of annual casualties. Today, this disease 
extends from Afghanistan to South Africa, including many Asian and South 
American countries. There is an estimated 3 billion people at risk of this 
disease and 250 million cases that result in approximately 1 million deaths 
every year (WHO 2008). Although these estimates cover 109 countries and 
territories, the bulk of the burden is attributed to Africa (Figure 1, (Hay, Guerra 
et al. 2009)), where the majority of deaths concern children under the age of 5 
and pregnant women. 
 
Figure 1: Stable spacial limits of P. falciparum malaria transmission (low to high, from yellow 
to red), low risk of transmission in dark grey, no risk in light grey. From (Hay, Guerra et al. 
2009). 
 
In the mid-twentieth century, malaria had a broader range than today. In 
1955, the World Health Organization launched the Global Malaria Eradication 
Program (GMEP). This campaign was successful in eliminating malaria from 
Europe, North Africa, North America, Australia and parts of Asia, the Middle 
East and South America. However, the disease persisted in the most 
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economically poor regions of the world (Sachs and Malaney 2002). The 
eradication program was abandoned and replaced with a long-term focus on 
control of the disease in 1969 (Snow and Marsh 2010). 
 
The reasons for this failure to eliminate malaria in the 1950ʼs and 1960ʼs is 
ascribed to many factors, including ecological, socio-political, economical and 
biological. They are manifold; here are a few (simplified) examples: First, the 
regions that were successful in eliminating malaria had temperate climates 
with seasonal transmission, which allowed for concentrated efforts in the end 
of the malaria season. Second, the political unrest in many countries in sub-
Saharan Africa, as they became independent, gave little support to the 
GMEP. Third, the very effective drug chloroquine was not used to treat native 
populations of endemic areas because it was deemed too expensive to 
distribute. Finally, the development of resistance to drugs and insecticides as 
well as the absence of any effective vaccine resulted in a failure of the GMEP. 
 
The two following decades of relaxed efforts to control malaria and increased 
drug resistance have resulted in a marked resurgence of disease and deaths 
due to malaria (Sachs 2002). Since the mid-1990ʼs, several initiatives, 
networks and foundations have boosted the efforts in malaria control and 
research. These include, non-exhaustively, the Multilateral Initiative on 
Malaria (MIM), the African Malaria Vaccine Testing Network (AMVTN), 
ACTMalaria-Asia, Roll Back Malaria (RBM), Medicines for Malaria Venture 
(MMV), Malaria Vaccine Initiative (MVI) and The Bill & Melinda Gates 
Foundation. Additionally, scientific consortiums have allowed for the 
sequencing of several Plasmodium and Anopheles genomes and the creation 
of the Malaria Research and Reference Reagent Resource Center (MR4). 
 
These renewed efforts and the advances in malaria research have brought 
back the eradication of malaria to the public debate (Tanner and de Savigny 
2008; Cohen, Moonen et al. 2010). Still, much effort will be needed to 
accomplish this elusive feat. As parasites develop novel resistance 
mechanisms to existing drug therapies, current research continues to 
discover new drugs to compete in this arms race (Dharia, Plouffe et al. 2010; 
Rottmann, McNamara et al. 2010). Additionally, although there is hope for the 
licensing of a vaccine that would be effective against clinical and severe 
disease (Casares, Brumeanu et al. 2010), sterile immunity remains elusive, 
  3 
which might allow for the parasite to evolve a counter attack. Unfortunately, 
this arms race may be an interminable one that will be financially 
unsustainable (Sinden 2010). 
 
1.2 PLASMODIUM SPECIES 
There are over 200 Plasmodium species, which all infect vertebrate animals; 
however, only five infect humans. These are P. falciparum, P. vivax, P. ovale, 
P. malariae and P. knowlesi. They have a complex life cycle that involves 
mosquitoes and primates, with several distinct morphological and 
physiological stages. The mosquitoes are of the genus Anopheles and the 
primates are primarily Homo sapiens, although other primates have been 
found to be susceptible to infections (Krief, Escalante et al. 2010). One 
exception is Plasmodium knowlesi, which was initially thought to infect only 
macaque monkeys, but has recently been shown to be widely distributed and 
life threatening to humans (Cox-Singh, Davis et al. 2008; Cox-Singh, Hiu et al. 
2010). 
 
These parasites are protozoa of the Apicomplexan phylum. They are haploid 
organisms during most of their life cycle, only becoming diploid briefly in the 
gut of the mosquito before undergoing meiosis. Therefore, within each host, 
the propagation of the parasite is accomplished through asexual 
multiplication. Figure 2 depicts the life cycle of Plasmodium falciparum, which 
is roughly similar to that of the other species. 
 
Briefly, from the perspective of humans, the cycle “starts” when an infected 
mosquito bites a human and injects, from its salivary glands, sporozoites into 
the skin. These sporozoites then migrate to blood capillaries in order to reach 
the liver, where they invade hepatocytes. The parasites differentiate and 
undergo a first asexual multiplication stage during approximately 14 days, 
resulting in tens of thousands of merozoites that burst from the infected 
hepatocytes. 
Released into the blood flow, these merozoites initiate the erythrocytic cycle 
of asexual multiplication. This cycle starts with the invasion of red blood cells 
(RBC) and lasts approximately 48 hours. Once the parasite has penetrated 
the RBC, it matures from ring stage trophozoite to mature trophozoite, during 
which it grows and prepares for chromosome replication. The transition from 
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trophozoite to schizont is marked by the first mitosis and schizogony 
continues until the last mitosis. Merogony is the assembly of nuclei and 
organelles into the merozoites. This late stage can then burst, releasing 8 to 
26 new merozoites. Parasite numbers increase exponentially in the blood 
stream of infected individuals until either the hostʼs immune system or 
chemotherapy controls its progress, or until the human host dies. 
Some parasites may take an alternative developmental pathway, transitioning 
from trophozoites into gametocytes (instead of schizonts), male and female 
sexual forms, that may then be taken up by a feeding mosquito. 
Within the mosquito gut, female and male gametocytes transform into one 
macro- and eight microgametes, respectively. One microgamete and one 
macrogamete can then fuse, mature and complete meiosis, to form a motile 
ookinetes that migrate through the cells of the stomach wall. Once this barrier 
crossed it encysts, creating a wart-like structure known as the oocyst. For the 
third iteration in the parasiteʼs life cycle, it proceeds to asexual multiplication 
resulting in the liberation of thousands of sporozoites that migrate to the 
mosquitoʼs salivary glands. Thus, the Plasmodium falciparum life cycle is 
completed... and starts over again, when the mosquito bites another human. 
 
 
Figure 2: Life cycle of the Plasmodium falciparum parasite. Courtesy of Dr. Johan Normark. 
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1.3 PLASMODIUM FALCIPARUM’S SURVIVAL WITHIN THE HUMAN 
HOST: PFEMP1, AN ANTIGENIC VARIANT PROTEIN FAMILY 
As a species, a successful infectious agent is an organism that manages to 
survive long enough within its host to spread to other hosts. However, 
vertebrates have developed an elaborate immune system that efficiently 
targets the non-self. In order to extend the length of infection, pathogens have 
evolved mechanisms to avoid being destroyed by their hostʼs immune 
system. Some, like Toxoplasma, invade and highjack host cells in order to 
hide from opsonizing antibodies and destruction, as well as to disseminate 
within the host (Lambert and Barragan 2010). However, P. falciparum has 
evolved its life cycle so as to inhabit a terminally differentiated de-nucleated 
human cell: the red blood cell. Contrary to most other cells in the human 
body, RBCs are devoid of almost all the features that allows Toxoplasma to 
survive within other cells. Therefore, the malaria parasite has to modify the 
RBC in order to feed and eliminate waste, as well as to export proteins for the 
evasion of host defenses (reviewed in (Goldberg and Cowman 2010)). Also, it 
is continuously multiplying, destroying and invading new RBCs every 48 
hours, necessarily exposing an array of proteins involved in these processes 
(Ferreira, Zilversmit et al. 2007). These modifications to the RBC make it 
vulnerable to the adaptive immunity and to clearance by the spleen, which 
removes damaged and old RBCs from the circulation (David, Hommel et al. 
1983; Udeinya, Miller et al. 1983). 
 
In such an environment, this parasite has to cope with two strong selective 
pressures: First, clearance by the spleen. Second, the generation of 
antibodies specific to the antigens it exposes at the surface of sporozites, 
merozoites and infected RBCs. One mechanism that addresses both 
pressures, in the infected RBCs, is antigenic variation of the Plasmodium 
falciparum Erythrocyte Membrane Protein 1 (PfEMP1) (Baruch, Pasloske et 
al. 1995; Smith, Chitnis et al. 1995; Su, Heatwole et al. 1995). 
 
The PfEMP1 proteins have been identified as the main ligands responsible for 
cytoadherence (Sherman, Eda et al. 2003) and rosetting (Rowe, Moulds et al. 
1997; Chen, Barragan et al. 1998). These phenomena result in the 
sequestration of late trophozoite and schizont infected RBCs in the deep 
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vasculature of host tissues, enabling the parasite to avoid clearance by the 
spleen (MacPherson, Warrell et al. 1985; Pongponratn, Riganti et al. 1985; 
Turner, Morrison et al. 1994; Silamut, Phu et al. 1999). 
However, expression of the PfEMP1 protein for such extended periods of time 
makes it the target of naturally acquired immunity (Bull, Lowe et al. 1998; Bull, 
Lowe et al. 1999). To counter the hostʼs ability to elaborate custom defenses 
against specific protein variants, the parasite has expanded the PfEMP1 
encoding genes, named var genes, to a polymorphic family of ~60 members 
per haploid genome (84 in 3D7 when pseudogenes are included). It switches 
the expression from one member of the family to another, in a mutually 
exclusive manner, only exposing one protein at the infected RBC surface at a 
time (Chen, Fernandez et al. 1998; Scherf, Hernandez-Rivas et al. 1998). 
 
This dogma has recently been questioned (Brolin, Ribacke et al. 2009; 
Sander, Salanti et al. 2009; Joergensen, Bengtsson et al. 2010); however, the 
experiments that show co-expression of two PfEMP1 proteins at the surface 
of the infected RBC are the result of in vitro selection. This situation remains 
to be shown for fresh isolates from patients (Joergensen, Bengtsson et al. 
2010). Also, it is unlikely that a large number of PfEMP1 proteins would be 
exposed simultaneously at the surface of the infected RBC as that would 
result in a rapid exhaustion of the antigenic repertoire. 
 
Although the sequestration of the infected RBC is posited to have evolved, in 
P. falciparum, to prevent its passage through the spleen (Deitsch, Lukehart et 
al. 2009), there is little direct evidence to support this. A recent case study of 
a splenectomized patient with falciparum malaria supports this idea 
(Bachmann, Esser et al. 2009). Bachmann et al. showed that the parasites 
found in the patient were unable to cytoadhere to various endothelial 
receptors and did not transcribe var genes.  
 
Whether immune evasion is the primary role or a necessary side effect of 
PfEMP1 proteins, it appears clear that it has a central impact on the 
establishment of chronic infections and the survival of the species. Figure 3 
shows a simplified diagram of the relationship between antigenic variation 
and pathogen transmission 
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1.4 ANTIGENIC VARIATION 
Antigenic variation is often broadly defined as the capacity for a pathogen to 
change its surface proteins in order to evade a host immune response. Many 
infectious organisms fulfill this definition, including viruses, bacteria and 
protozoan parasites. However, these consist of different mechanisms such as 
phase variation, antigenic drift and shift, as well as antigenic variation sensu 
stricto (Mumford 2007; Deitsch, Lukehart et al. 2009). 
 
Figure 3 represents a general idea of the link between survival, transmission 
and antigenic variation / antigenic switching (Turner 2002). 
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Phase variation is mostly an attribute of some bacteria that undergo frequent 
and usually reversible phenotypic changes resulting from genetic or 
epigenetic alterations at specific loci. It is characteristically the switch ON / 
switch OFF of a specific phenotype (van der Woude and Bäumler 2004; 
Wisniewski-Dyé and Vial 2008). This is used by bacteria to generate intra-
population diversity that is important to escape host defenses or in niche 
adaptation. 
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Antigenic drift and shift are usually applied to viruses. Antigenic drift is the 
rapid accumulation of mutations during replication. The term antigenic shift is 
sometimes used to express a leap in the modification of the surface protein 
due to recombination events (Mumford 2007). In order to avoid clearance by 
hostsʼ immune system or simply to allow for re-infection, the virus needs to 
vary its antigenic proteins. These mutated forms are often referred as 
immune-escape variants because they have accumulated a sufficient number 
of amino acid changes to avoid recognition by vaccinated and unvaccinated 
hosts alike (Boni 2008). 
 
Antigenic variation sensu stricto is usually characterized as the switching 
between members of a multicopy gene family, which involves a complicated 
mechanism of activation and silencing (Craig and Scherf 2003). C.M. Turner 
suggests the following requirements to fulfill the definition of antigenic 
variation (Turner 2002): 
 
♦ Capacity to interact with the environment; 
♦ Mutually exclusive expression of variable antigens in each cell within 
an infection; 
♦ Mutually exclusive expression in the within-host pathogen population; 
♦ Protein variants must be antigens confronted with functional 
immunity; 
♦ Capacity for population growth within a host. 
 
Interestingly, these definitions do not constrain the function of antigenic 
variant proteins. Indeed, some parasites, such as the Trypanosoma, have 
developed antigenic variation to fulfill the main function of immune evasion 
(Morrison, Marcello et al. 2009). However, as we have seen in Plasmodium 
falciparum, the PfEMP1 protein family couples the immune evasion function 
with a binding function, which allows the parasite to sequester and avoid 
splenic clearance. 
 
Unfortunately, the requirements of Turnerʼs strict definition may not always be 
practical to evaluate, making it difficult to determine whether a multicopy 
protein family is antigenic variant or not. Also, the first condition would 
exclude the free-living organisms that express antigenic variants (Simon and 
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Schmidt 2007) as they would not induce “immunity”. Nevertheless, they 
suggest the possibility of the recognition of specific surface antigens by the 
ciliate predator Didinium nasutum, which would explain the need for antigenic 
variation in the absence of immunity (Simon and Schmidt 2007). 
 
1.5 ANTIGENIC VARIATION AND THE OTHER VARIANT PROTEIN 
FAMILIES OF PLASMODIUM FALCIPARUM 
In P. falciparum, antigenic variation is often solely ascribed to the PfEMP1 
protein family, which is described as the major surface molecule of the 
infected RBC (Barry, Leliwa-Sytek et al. 2007; Frank and Enderes 2010). As a 
result, much effort has been focused on the PfEMP1 protein family (a 
PubMed search for PfEMP1 yields 272 versus 74 for all three of the other 
multicopy families). However, P. falciparum exposes three other multicopy 
variant protein families at the surface of the infected RBC: PfMC-2TM, 
STEVOR and RIFIN. These proteins are encoded by the pfmc-2tm, stevor 
and rif genes, short for Plasmodium falciparum Maurerʼs Cleft two 
transmembrane protein, subtelomeric variable open reading frame and 
repetitive interspersed family, respectively (Cheng, Lawrence et al. 1997; 
Cheng, Cloonan et al. 1998; Fernandez, Hommel et al. 1999; Kyes, Rowe et 
al. 1999; Sam-Yellowe, Florens et al. 2004). 
 
According to the most current gene annotations found at www.genedb.org, 
there are 12 protein coding pfmc-2tm genes. The stevor are a small family of 
31 protein coding genes and rif is the largest gene family of P. falciparum with 
161 protein coding genes. 
 
All three protein families have been described as variable surface antigens 
(Fernandez, Hommel et al. 1999; Kyes, Rowe et al. 1999; Lavazec, Sanyal et 
al. 2006; Niang, Yan Yam et al. 2009). In particular, RIFIN and STEVOR 
proteins are recognized by human antibodies that are induced during natural 
P. falciparum infections (Abdel-Latif, Khattab et al. 2002; Abdel-Latif, Dietz et 
al. 2003; Schreiber, Brattig et al. 2006; Schreiber, Khattab et al. 2008). 
However, this has not been unambiguously shown for PfMC-2TM proteins 
(Sam-Yellowe, Florens et al. 2004; Tsarukyanova, Drazba et al. 2009). It is 
therefore impossible to confirm interaction with the environment for this 
protein family. 
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Strict mutual exclusion of the expression of these proteins has not been 
proven, but there is evidence for the expression of a restricted number of 
variants (Lavazec, Sanyal et al. 2007; Wang, Magistrado et al. 2008; Cabral 
and Wunderlich 2009; Niang, Yan Yam et al. 2009). In the case of RIFIN and 
STEVOR proteins, it is clear that several variants can be expressed at the 
same time, in the same cell (Petter, Haeggström et al. 2007; Niang, Yan Yam 
et al. 2009). These proteins apparently do not fulfill the mutually exclusive 
protein expression criterium. 
 
Finally, a recent publication has reported the absence of multicopy gene 
family expression in P. falciparum from a splenectomized malaria patient. 
More precisely they report on the apparent down regulation of var, stevor and 
a sub-type of rif genes (Bachmann, Esser et al. 2009). One of the authorsʼ 
conclusions is that the expression of these proteins is required for 
sequestration and avoidance of splenic clearance. Therefore, in a normal 
context, the expression of these proteins would enhance the survival and 
growth of the parasite population. The authors have also reported on the 
maintenance of the expression of the pfmc-2tm genes and the other sub-type 
of rif genes. However, this does not necessarily imply that the expression of 
these proteins does not participate in the growth of the population. On the 
contrary, the maintenance of their expression marks their importance for the 
survival of the parasite. Hence, fulfilling Turnerʼs last requirement. 
 
As I mentioned above, Turnerʼs requirements for a protein family to be 
antigenic variant, sensu stricto, are difficult to prove/disprove. However, if we 
adopt a broader definition of antigenic variation, it becomes reasonable to 
assign RIFIN and STEVOR sequences as antigenic variant protein families. 
 
1.6 RIFIN AND STEVOR PROTEINS 
The RIFIN protein family was first described as “interspersed repetitive DNA 
elements” (Weber 1988) and formally annotated as RIFIN in the publication of 
the chromosome 2 of Plasmodium falciparum, although, this name was used 
indiscriminately for both RIFIN and STEVOR proteins (Gardner, Tettelin et al. 
1998). The STEVOR proteins were first reported as 7H8/6, multicopy genes 
found in all P. falciparum strains tested (Limpaiboon, Taylor et al. 1990). 
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In addition to the brief description of RIFIN and STEVOR proteins provided by 
Gardner (Gardner, Tettelin et al. 1998), Cheng (Cheng, Cloonan et al. 1998) 
also described the stevor and rif gene organization and deduced protein 
characteristics, suggesting that these sequences are part of a protein super 
family. According to their analyses, both rif and stevor genes are composed of 
two exons and have a subtelomeric location, centromeric to the var genes. 
The first exon is short and encodes a putative signal peptide or anchor, 
whereas the second exon encodes the bulk of the 27 to 35 kDa protein. 
Predictive methods estimated that these proteins possessed three 
transmembrane (TM) domains (Figure 3), the first of which corresponding to 
the predicted signal sequence. 
 
Multiple sequence alignments, of the deduced RIFIN and STEVOR proteins 
available at the time, showed that these sequences were fairly conserved 
except for the region between the two predicted TM domains, which was 
highly variable. The deduced topology of the protein placed the relatively 
conserved N-terminal third of the protein, as well as the very conserved C-
terminus, on the cytoplasmic side of the membrane and the highly 
polymorphic loop on the extracellular side. These observations as well as the 
detection of a limited number of transcripts, in the trophozoite and schizont 
stages of the erythrocytic cycle, led both Cheng et al. (Cheng, Cloonan et al. 
1998) and Gardner et al. (Gardner, Tettelin et al. 1998) to suggest that rif and 
stevor genes may be clonally variant. 
 
It was only a year later that RIFIN proteins were shown to be expressed at the 
surface of the infected RBC (Fernandez, Hommel et al. 1999; Kyes, Rowe et 
al. 1999). Eventually, the trafficking of RIFIN proteins through Maurerʼs cleft, 
as well as their localization in gametocytes and merozoites was also 
demonstrated (Haeggström, Kironde et al. 2004; Haeggström, VON Euler et 
al. 2007; Petter, Haeggström et al. 2007; Petter, Bonow et al. 2008). 
Conversely, the STEVOR proteins were initially found to localize to the 
Maurerʼs cleft compartment in the infected RBC cytoplasm, but not to the 
RBC surface (Kaviratne, Khan et al. 2002; McRobert, Preiser et al. 2004; 
Przyborski, Miller et al. 2005). However, García et al. (García, Puentes et al. 
2005) described in 2005 the binding of STEVOR derived peptides to normal 
RBCs. Eventually, others found evidence of STEVOR proteins expressed at 
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the infected RBC and merozoite surfaces, as well as in gametocytes and 
sporozoites (McRobert, Preiser et al. 2004; Lavazec, Sanyal et al. 2006; 
Blythe, Yam et al. 2008; Khattab, Bonow et al. 2008; Niang, Yan Yam et al. 
2009). 
 
The development of large scale genomics, proteomics and microarray 
projects added to the evidence of transcription and protein expression of both 
RIFIN and STEVOR in multiple stages of the P. falciparum life cycle, including 
gametocytes, merozoites and sporozoites (Florens, Washburn et al. 2002; Le 
Roch, Zhou et al. 2002; Bozdech, Llinás et al. 2003; Le Roch, Zhou et al. 
2003; Florens, Liu et al. 2004; Le Roch, Johnson et al. 2004; Daily, Le Roch 
et al. 2005; Llinás, Bozdech et al. 2006). 
 
The publication of the genome sequence of the Plasmodium falciparum 
parasite allowed for genome wide analysis of the multicopy gene families 
(Gardner, Hall et al. 2002; Lavstsen, Salanti et al. 2003; Joannin, Abhiman et 
al. 2008; Bultrini, Brick et al. 2009). In particular, one of the articles presented 
in this thesis is largely based on the availability of this data. The intra-genome 
diversity discovered within the 3D7 strain has prompted the investigation of 
intra-population diversity: similarly to the var gene family, there seems to be 
an extensive polymorphism of rif and stevor sequences within parasite 
populations (Albrecht, Merino et al. 2006; Volkman, Sabeti et al. 2007; Blythe, 
Niang et al. 2009) 
 
Some work has focused on the transcription of rif or stevor genes, identifying 
basic transcriptional elements of some rif genes and the antigenic switching 
of rif and stevor genes (Sutherland 2001; Tham, Payne et al. 2007; Blythe, 
Yam et al. 2008; Blythe, Niang et al. 2009; Cabral and Wunderlich 2009; 
Wang, Mwakalinga et al. 2010). Unfortunately, published research on these 
gene families is sometimes designed to correlate their results with the 
expression of the var gene family, often underestimating the importance of 
their basic findings regarding rif and stevor (Sharp, Lavstsen et al. 2006; 
Tham, Payne et al. 2007; Wang, Magistrado et al. 2008). 
 
Our sub-division of the RIFIN family into coherent groups (Joannin, Abhiman 
et al. 2008) has triggered the exploration of divergent protein localizations, 
characteristics and transcription patterns (Petter, Haeggström et al. 2007; 
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Petter, Bonow et al. 2008; Bachmann, Esser et al. 2009; Bultrini, Brick et al. 
2009). 
 
With the addition of the manuscripts presented in this thesis, this summary 
represents the current extent of the knowledge of RIFIN and STEVOR 
proteins. The presence of these proteins in so many stages of the parasites 
life cycle as well as the high diversity within these gene families tells us that 
there is still much work to accomplish and many functions to discover. 
 
1.7 PROTEIN FAMILIES, ANTIGENIC VARIANT PROTEIN FAMILIES AND 
PROTEIN FUNCTION(S) 
Protein families: Gene duplication (Ono 1972) is a major force in the 
evolution of genomes, usually caused by unequal crossing over of 
chromosomes. A gene duplication event initially produces two identical copies 
of the same gene and evolutionary forces drive the fate of these genes: 
 
♦ Functional redundancy: the two copies are maintained in order to produce 
large quantities of the encoded protein (Force, Lynch et al. 1999). 
♦ Pseudogenisation: one of the two copies may accumulate deleterious 
mutations and loose its function (Wilde 1986). 
♦ Neofunctionalization: one of the two copies develops a new function while 
the other copy maintains the original function (Prince and Pickett 2002). 
♦ Subfunctionalization: the original function may be sub-divided among the 
duplicated genes (Force, Cresko et al. 2005). 
 
Gene duplications, in combination with speciation events, results in 
complicated relationships among genes/proteins. The following definitions 
describe these relationships (see also Figure 3): Homology describes the 
common evolutionary origin of two or more traits. They are derived from a 
common ancestor. In genetics, the traits are protein and DNA sequences, of 
which sequence similarity is compared. Homologous sequences include both 
orthologs and paralogs. Orthology and paralogy are two terms that describe 
different relationships between homologous sequences (Fitch 1970). 
Orthologs are sequences that derive from a single gene in the common 
ancestor through vertical descent and separated by speciation events. 
Paralogs are homologous sequences that were separated by a gene 
duplication event. In this case, the two copies occupy two different positions 
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within the same genome. 
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Distinguishing between orthologs and paralogs is important because 
orthologous proteins are more likely to have a similar function between two 
species than paralogous proteins within a species, as the latter tend to 
undergo sub- or neofunctionalization. However, orthology does not imply 
similarity of function. Nevertheless, homology, orthology and paralogy are 
commonly used in bioinformatics to assign putative functions to unknown 
proteins discovered through large scale sequencing projects. 
 
Clusters of related protein sequences created by successive gene duplication 
and speciation events are known as a homologous protein family. 
Establishing a group of sequences by similarity is often a statement that they 
might have similar structures and in turn similar functions. Often, a protein 
family will have evolved to accommodate a wide range of functions, even 
though the general function may be the same for all the proteins (e.g. kinases 
with different substrate specificity). A sub-family can be viewed as a set of 
proteins with a related functions and domain organizations resulting from a 
particular line of evolution within a family. 
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Protein domains are fundamental units for protein evolution, typically defined 
as independent and globular folding units within a three-dimensional protein 
structure. One of the most widely used protein domain databases is Pfam 
(Finn, Mistry et al. 2010). In P. falciparum, the PfEMP1 proteins are 
composed of multiple domains (Lavstsen, Salanti et al. 2003), whereas the 
RIFIN and STEVOR proteins are only composed of one domain. 
 
Antigenic variant protein families…: One particular fact about antigenic 
variant sequences is that they are usually unique to the species (or a small 
group of closely related species) to which they belong. For instance, var, rif 
and stevor genes are unique to Plasmodium falciparum and P. reichenowi. 
The necessary consequence is that studying an antigenic variant gene family 
is often synonymous with studying a paralogous gene family, as all the 
variants derive from gene duplication events. One should therefore be aware 
of possible changes in function between subsets of the protein family. 
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The RIFIN and STEVOR proteins have been described by one Pfam domain, 
whereas the PfEMP1 proteins are composed of a mosaic of Duffy_binding 
(DBL) and CIDR domains. These groupings are useful for identifying 
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divergent sequences belonging to the same protein families, but they where 
solely based on a homology basis and not on functional basis. Different 
PfEMP1 variants have different binding properties to host receptors (Figure 
4). The classification of these domains does not reflect for these shifts in 
function, which proves to be a limitation of these domain models. 
Figure 6: Organization of the PfEMP1 protein family. (A) Genomic organization of 
var genes in sub-telomeric and central positions. (B) PfEMP1 location on the infected 
RBC surface and the summary of the different binding affinities of the different 
domains. (C) Gene structure. Courtesy Johan Normark. 
 
 
… and Protein Function: Therefore, an important step in studying antigenic 
variant protein families is determining whether their grouping into one family 
has functional relevance or not. Several studies have aimed at deciphering 
the antigenic variant “languages” of the DBL and CIDR domains of PfEMP1 
proteins, either by looking for binding properties or by searching for 
associations of motifs and severity of disease (Dahlbäck, Rask et al. 2006; 
Rasti, Namusoke et al. 2006; Normark, Nilsson et al. 2007). These are good 
steps in the right direction; however, they still remain too focused on 
sequence diversity and motifs. Future research should aim at compiling the 
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empirical data obtained from individual sequences and integrate them into a 
model with which to compare all available data. 
 
In the end, the main goal of grouping sequences is to infer function, not family 
relationships. 
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2 AIMS OF THE THESIS 
 
 
2.1 GENERAL AIM 
The general aim of this thesis is to describe and most importantly to simplify the RIFIN 
antigenic variant protein family. 
 
2.2 SPECIFIC AIMS 
The specific aims of the work included in this thesis are to: 
 
i. Determine if the RIFIN protein family is a cohesive group, all members 
fulfilling the same function (Paper I) 
ii. Develop the necessary tools to make the results of my work accessible 
and usable by fellow researchers (Paper II and IV) 
iii. Determine the topology of the A-RIFIN and B-RIFIN proteins (Paper III) 
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3 RESULTS AND DISCUSSION 
3.1 PAPER I: SUB-GROUPING AND SUB-FUNCTIONALIZATION OF THE 
RIFIN MULTI-COPY PROTEIN FAMILY 
Antigenic variation is a phenomenon found in pathogenic organisms that need 
to avoid their hostʼs immune system. In order to efficiently avoid the immune 
system, the malaria parasite Plasmodium falciparum has amplified several 
gene families, including the var, stevor and rif genes. The latter is the largest 
family of this species. However, strict mutual exclusion of protein expression 
has not been ascertained for this family. In effect, several publications show 
evidence that multiple RIFIN proteins are expressed at the same time 
(Fernandez, Hommel et al. 1999; Kyes, Rowe et al. 1999; Petter, Haeggström 
et al. 2007; Petter, Bonow et al. 2008). This apparent contradiction to the 
status of “antigenic variant family”, as well as the large number of sequences 
belonging to this group, prompted us, in Paper I, to investigate this protein 
family. 
 
Using phylogenetic methods, we determined that the RIFIN proteins can be 
classified into two major groups: A-type and B-type RIFIN proteins. Although 
the groups are determined by a large number of amino acids specific to each, 
major determinants are a 25 amino acid residue indel present in A-type and 
absent from B-type RIFIN proteins, as well as a different number of conserved 
cysteine residues, ten for A-type and five for B-type sequences. In addition to 
these two major groups, the B-type RIFIN proteins are further divided into 
three sub-groups: B1-, B2- and B3-RIFIN proteins. 
 
Where the conserved region of B-type RIFIN is clearly distinct from the 
conserved region of A-type RIFIN proteins, the large variable region of B3-
type sequences has similarities with that of the A-type RIFIN. We suggest this 
to be the result of frequent recombination events, which are expected to 
generate the diversity of antigenic variant proteins in Plasmodium falciparum, 
although this could also be the result of a very high mutation rate specific to 
the variable region of these sequences. Our analysis of 500 bp of up- and 
down-stream non-coding sequence also supports the sub-grouping into two 
major groups, although there is no congruence within the A- and B-RIFIN sub-
groups. 
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This division of the RIFIN protein family is also substantiated by differential 
localizations found by others (Petter, Haeggström et al. 2007). These 
differences suggest that these proteins may have different functions. 
 
To test this hypothesis, we carried out function shift analysis (Abhiman and 
Sonnhammer 2005) of our sub-groups. This method consists of comparing 
the conservation state of each amino acid between the two groups. Amino 
acid positions can be either variable or conserved for the whole family, in 
which case they do not distinguish the two groups. However, Rate Shifting 
Sites (RSS) and Conservation Shifting Sites (CSS) represent important 
determinants of function shift between sub-groups (Figure 5). The first, RSS, 
are amino acid position that are variable in one group but conserved in the 
other. The second, CSS, are positions that are conserved in both groups, but 
with a different amino acid. We have determined that the number of both 
types of shifting sites between A- and B-RIFIN proteins is consistent with a 
shift in their function. 
 
Our findings allow us to simplify this large protein family into meaningful sub-
groups. We expect this to facilitate the study of RIFIN proteins, in particular 
the discovery of their functions. 
 
 
Figure 7: Schematic explanation of CSS and RSS positions. In the CSS position, the 
conserved amino acid of group A is aspartic acid (D) whereas in group B it is 
glutamine (Q). In the RSS position, the group A has a conserved cysteine (C) 
whereas the group B has either glycine, alanine, isoleucine or leucine (G, A, I and L, 
respectively). (Abhiman 2006) 
  21 
3.2 PAPER II: RSPRED, A SET OF HIDDEN MARKOV MODELS TO 
DETECT AND CLASSIFY THE RIFIN AND STEVOR PROTEINS OF 
PLASMODIUM FALCIPARUM 
Determining that a protein family can be divided into meaningful sub-groups is 
a crucial step in understanding large groups of homologous sequences. 
However, classifying an unknown protein needs to be accessible to a broad 
range of researchers for the sub-grouping to be most useful. In Paper II we 
describe a new tool, which we named RSpred, consisting of a set of hidden 
Markov models and an evaluation program to automatically detect and 
classify RIFIN and STEVOR proteins into their sub-groups. 
 
To accomplish this, we needed a large number of curated RIFIN and 
STEVOR sequences, including sufficient proteins of each sub-group. We 
extracted the RIFIN and STEVOR protein sequences from the Plasmodium 
falciparum reference strain genome, 3D7, as well as those present in the 
Uniprot Knowledgebase. As these sequences were not sufficient, we chose to 
manually curate the RIFIN and STEVOR sequences from the DD2 and HB3 
strains that were sequenced at the Broad Institute of Harvard and MIT. In 
addition to 30 new rif and stevor genes, we determined that over 25% of the 
automatic predictions were incorrect. 
 
Using these newly annotated sequences as well as those from the reference 
strain, we revised our results from Paper I. We confirmed the sub-grouping of 
RIFIN proteins into A-RIFIN, B1- and B2-RIFIN sequences. However, we 
realized that the B3-RIFIN proteins do not have any specific characteristic that 
would define them as a cohesive group. We have therefore decided to 
rename them B-RIFIN sequences. As we had not yet investigated the 
STEVOR proteins, we verified the coherence of the group. The inclusion of 
the curated DD2 and HB3 data sets allowed us to detect a small number of 
divergent sequences that we designated STEVOR-like sequences. 
 
We used our manually annotated RIFIN and STEVOR sub-groups (with the 
exception of the STEVOR-like) to train hidden Markov models to detect each 
type of sequence. A program was written to evaluate the results according to 
manually set cut-offs. We describe the limits of detection and the sensitivity of 
our method. When compared to the existing tools, RSpred proves to be more 
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sensitive and more specific than Pfam or TIGRFAMs, as neither sort these 
proteins into sub-groups. 
 
3.3 PAPER III: RIFIN PROTEIN TOPOLOGY: A NEW PERSPECTIVE ON 
PLASMODIUM FALCIPARUM VARIABLE SURFACE ANTIGENS 
RIFIN proteins have traditionally been described as “two transmembrane” 
proteins (Cheng, Cloonan et al. 1998; Kyes, Rowe et al. 1999; Lavazec, 
Sanyal et al. 2006). However, a recent publication from Bultrini et al. (Bultrini, 
Brick et al. 2009) challenges this statement: they describe a different protein 
topology between the two major RIFIN sub-groups described in Paper I. We 
have decided, in Paper III, to investigate A- and B-RIFIN protein topology 
from a bioinformatics as well as a biochemical perspective. 
 
We applied nine different protein transmembrane prediction algorithms to two 
RIFIN proteins and compared their results. About half of them predict the A-
RIFIN protein to have two transmembrane domains, whereas seven out of 
nine programs show this prediction for the B-RIFIN protein. Both proteins are 
predicted to have a C-terminal transmembrane region by all of the algorithms 
tested. However, the ambiguity lies in the middle of the protein, at the frontier 
between the fairly conserved and the very variable region of RIFIN proteins. 
This ambiguity prompted us to use a biochemical in vitro method to determine 
whether A- and B-RIFIN proteins have either one or two transmembrane 
regions. 
 
We used a glycosylation mapping approach (Devoto, Piffanelli et al. 1999; 
van Geest, Nilsson et al. 1999; Lundin, Nordström et al. 2006) to map the 
location of the conserved and the variable regions of the two RIFIN proteins 
relative to the membrane of dog pancreas rough microsomes (i.e. 
endoplasmic reticulum equivalent). This method allows us to show that both 
the conserved and variable regions of RIFIN proteins are exposed to the 
lumen of the microsomes. Consequently, both A- and B-RIFIN proteins only 
have one transmembrane region in the C-terminus of the protein. These 
results also imply that RIFIN proteins expose the bulk of their sequence to the 
extracellular environment. Finally, we discuss the probability of different 
protein foldings that would allow these proteins to be exposed to the immune 
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system while protecting their conserved regions. 
 
These results resolve the contradiction found in the literature. They have 
obvious implications on the conceptual thoughts on the function of RIFIN 
proteins as well as on the design of future experiments. 
 
3.4 PAPER IV: VARDB: A PATHOGEN-SPECIFIC SEQUENCE 
DATABASE OF PROTEIN FAMILIES INVOLVED IN ANTIGENIC 
VARIATION 
Antigenic variation and drift are widespread phenomena that allow pathogenic 
organisms to avoid their hostʼs immune system and establish chronic 
infections. Although these organisms are evolutionarily diverse, they have 
independently developed common mechanisms to enable this ability to 
mutate and/or recombine their antigenic genes, and sometimes switch the 
expression of these genes. This results in an accumulation of genetic 
variability, which is a hallmark of antigenic variation. As the products of these 
genes are generally unique to each pathogen, research on antigenic variation 
is most often focused on individual species and is even, within species, 
usually restricted to only one of the antigenic variation gene families. This 
compartmentalization of research on antigenic variation often makes it difficult 
to find pertinent information from other gene families/pathogenic species to 
compare with oneʼs own data. In addition to these difficulties, existing data 
from each gene family is often scattered across different databases and 
sometimes only included in the supplemental information provided with 
publications. 
 
We developed the varDB database to serve as a repository for antigenic 
variant sequences, as well as their associated features. Regrouping antigenic 
variant data from multiple organisms in one centralized resource is also 
intended to make research from many multicopy gene families accessible and 
easily comparable. 
 
The current varDB release (v4) includes over 83878 DNA sequences, with 
46216 protein translations, 23 diseases, 32 pathogens and 46 gene families. 
The figure 6 briefly describes the sequence mining pipeline. 
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Figure 8: Sequence mining pipeline of the varDB database (Hayes, Diez et al. 
2008).  
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4 CONCLUDING REMARKS AND PERSPECTIVES 
“What is the function of RIFIN proteins?” 
That is the question I was repetitively asked during the first two years of my 
PhD studies... Today, I am still unable to answer this question; however, 
through the work my collaborators and I have accomplished, I believe we 
have set conceptual ideas and resources that will direct future research in the 
right direction. 
 
The work presented in this thesis can be summarized with the following major 
advancements: 
 
♦ Simplification of the RIFIN family into meaningful sub-groups; 
♦ Prediction of function shift between the two major RIFIN sub-
groups; 
♦ Development of a tool, RSpred, for the detection and classification 
of RIFIN and STEVOR sub-groups; 
♦ Determination of A- and B-RIFIN protein topology; 
♦ Development of a common resource and repository for antigenic 
variation sequence data. 
 
These past two decades have seen the rise of mass sequencing, whole 
genome transcriptomics and proteomics and an increasing belief that bigger 
is better… But is it really? 
 
The study of antigenic variant proteins families in Plasmodium species has 
unfortunately taken the route of “bigger is better, the more the merrier”. Large-
scale projects result in the discovery of many previously unknown genes and 
proteins, some of which may be linked by homology. The result is the creation 
of large protein families based on the suspicion of paralogy or orthology 
without further proof of concept (e.g. the PIR, VIR and YIR super families (Del 
Portillo, Fernandez-Becerra et al. 2001; Janssen, Phillips et al. 2004; 
Cunningham, Jarra et al. 2005)). All of these large multicopy protein families 
need to be reexamined for stronger evidence of functional similarity and 
eventually sub-grouped accordingly. 
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If we want to find out how these proteins work and are involved in disease, we 
need to simplify them to a manageable model, where the elucidation of the 
properties and functions of a limited number of proteins will truly reflect the 
state for the larger group. 
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